Archives
- 2026-11
- 2026-10
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
Indole-3-pyruvic Acid: Protocols and Innovations in Bench Re
2026-06-11
Indole-3-pyruvic acid (IPA) enables precise control in both plant hormone and immunology workflows, bridging advanced auxin biosynthesis modeling and translational disease studies. This article delivers stepwise protocols, troubleshooting insights, and unique assay guidance inspired by recent mechanistic discoveries, establishing IPA from APExBIO as an essential research tool.
Exo1 for Membrane Trafficking Inhibition: Protocols & Insigh
2026-06-11
Exo1 (methyl 2-(4-fluorobenzamido)benzoate) enables acute, ARF1-specific exocytic pathway inhibition, setting it apart from legacy agents for membrane trafficking studies. Its distinct mechanism and rapid action provide superior temporal control in exocytosis and extracellular vesicle assays.
Single-Cell Insights Reveal BCL-2 as a Target in CRPC Hetero
2026-06-10
This study integrates single-cell imaging, mechanistic modeling, and a Phase Ib clinical trial to validate BCL-2 as a therapeutic target across heterogeneous castration-resistant prostate cancer (CRPC) subtypes. The findings highlight how androgen receptor (AR) pathway inhibition induces BCL-2, revealing a vulnerability that spans both AR+ and AR-/lo prostate cancer cell populations.
Cyclo (-RGDfC): Precision αvβ3 Integrin Targeting for Cancer
2026-06-10
Cyclo (-RGDfC) is a cyclic peptide with high specificity for the integrin αvβ3 receptor, enabling robust tumor targeting and reproducible cell adhesion assays. Its stability and molecular precision make it a preferred reagent for angiogenesis research and integrin-mediated signaling studies.
Phosbind Acrylamide: Precision Tools for Phosphorylation Res
2026-06-09
Protein phosphorylation is central to cellular signaling and disease, but traditional detection methods struggle with specificity, throughput, and dynamic range. This thought-leadership article explores how Phos binding reagent (Phosbind) acrylamide, an advanced phosphate-binding reagent from APExBIO, empowers translational researchers to resolve complex phosphorylation events—especially in the context of PTM crosstalk such as O-GlcNAcylation—without antibody limitations. Drawing on recent mechanistic insights, we examine strategic experimental approaches, competitive technologies, and translational implications in neuroscience and oncology.
Exosomal HMGB1 Drives Endothelial Injury in Lupus Nephritis
2026-06-09
This study demonstrates that HMGB1-loaded exosomes from podocytes directly mediate glomerular endothelial cell (GEC) injury in lupus nephritis, acting through upregulation of TRIM27. The work provides mechanistic evidence for the role of exosome-mediated signaling in kidney damage and supports the use of exosome release inhibitors for dissecting intercellular disease pathways.
P2RX1 Drives Mitochondrial Apoptosis in Ph+ ALL via Ca2+/CaM
2026-06-08
Li et al. (2025) reveal that P2RX1 overexpression enhances mitochondrial apoptosis in Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) by modulating intracellular calcium signaling and suppressing PI3K/Akt survival pathways. These findings provide new mechanistic insight into apoptosis regulation in drug-resistant leukemia and highlight the importance of precise programmed cell death detection in translational research.
Sulfamonomethoxine: Pharmacology, Environmental Fate, and Su
2026-06-08
Explore Sulfamonomethoxine as a broad-spectrum antibiotic for veterinary and aquaculture use. This article reveals its advanced pharmacological mechanisms, environmental biotransformation, and protocols for responsible application—providing unique decision-making insights for sustainable research and practice.
PBS (Phosphate-Buffered Saline): Technical Use and Protocols
2026-06-07
PBS (Phosphate-Buffered Saline, SKU K2818) addresses the need for a sterile, isotonic buffer with physiological pH and osmolarity control, supporting routine laboratory workflows such as cell washing and substance dilution. It is not intended for diagnostic or clinical applications and should be reserved for scientific research in vitro.
Primidone (Mysoline): Precision Protocols for TRPM3 & RIPK1
2026-06-06
Primidone (Mysoline) stands out as a dual TRPM3 and RIPK1 inhibitor, enabling translational research across neurodevelopmental and neurodegenerative models. This guide synthesizes current evidence, protocol enhancements, and troubleshooting to help labs unlock robust, reproducible results.
Fosinopril Sodium: Pharmacokinetics and Clinical Potential i
2026-06-05
This article examines the pivotal findings of Shionoiri et al. (1997) regarding fosinopril sodium's unique pharmacokinetic profile and its implications for hypertension and cardiovascular disease research. The study clarifies how the dual renal and hepatic elimination of fosinoprilat distinguishes it from other ACE inhibitors, supporting its use in diverse patient populations and experimental models.
Antipyrine (SKU B1886): Reliable Solutions for CNS Assays
2026-06-05
This article provides an evidence-driven exploration of Antipyrine (SKU B1886) for laboratory workflows in blood-brain barrier, pharmacokinetic, and cell viability research. Drawing on recent high-throughput model data and real-world scenarios, it demonstrates how Antipyrine’s verified purity and solubility support robust, reproducible CNS drug discovery. Practical Q&A blocks address experimental design, protocol optimization, and vendor selection for biomedical scientists.
Ceftazidime in Gram-Negative Infection Research: Protocol &
2026-06-04
Ceftazidime, a third-generation cephalosporin, delivers robust β-lactamase resistance and exceptional performance in Gram-negative bacterial infection research—particularly for modeling Pseudomonas aeruginosa and multidrug resistance. This article translates recent breakthroughs in transmission dynamics and assay design into actionable protocols and troubleshooting for advanced respiratory infection models.
VX-745: p38α MAPK Inhibitor for Precision Inflammation Resea
2026-06-04
VX-745 empowers researchers to dissect the p38 MAPK signaling pathway with unprecedented specificity, thanks to its dual-action inhibition and dephosphorylation-enhancing mechanism. From advanced arthritis models to overcoming drug resistance in multiple myeloma, VX-745 offers robust, reproducible assay performance and new avenues for translational research.
Applied Workflows with the Live-Dead Cell Staining Kit
2026-06-03
Unlock precise cell viability analysis using Calcein-AM Propidium Iodide staining. This comprehensive guide details experimental workflows, troubleshooting, and advanced applications for the APExBIO Live-Dead Cell Staining Kit—empowering rigorous, reproducible results across diverse research settings.
8052 records 19/537 page Previous Next First page 上5页 1617181920 下5页 Last page